CombiMatrix Corp, a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental disorders, has launched its Targeted Array for Prenatal Analysis.
Read More
To determine how recommendations for chronic kidney disease testing in laboratory and point-of-care environments are shifting, CLP spoke to Robert H. Christenson, PhD, professor of pathology and medical and research technology at the University of Maryland School of Medicine and past president of the American Association for Clinical Chemistry.
Read More
Featured products include laboratory information systems, analytics solutions, and population analysis tools.
Read More
The Victor EnLite and EnLite Neonatal TREC kit from PerkinElmer is the first commercially available screening test in the United States and Canada for severe combined immunodeficiency, known as “Bubble Boy” disease. Affecting an estimated 1 in 58,000 newborns each year, SCID is an inherited genetic condition that makes it extremely difficult to fight off infections.
Read More
The settlement between Illumina and Sequenom creates a pool for joint use of the companies’ intellectual properties in noninvasive prenatal testing.
Read More